{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T23:50:23Z","timestamp":1772495423243,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Department of Science and Technology, Govt. of West Bengal and the Indian Council of Medical Research","award":["758 (sanc)\/ST\/P\/S&T\/9G-8\/2014 & VIR\/5\/2019\/ECD-1"],"award-info":[{"award-number":["758 (sanc)\/ST\/P\/S&T\/9G-8\/2014 & VIR\/5\/2019\/ECD-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10947-x","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T07:45:23Z","timestamp":1747381523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of hepatitis C virus genotype on the efficacy of the direct-acting antivirals in chronic kidney disease patients in West Bengal, India"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3332-2052","authenticated-orcid":false,"given":"Sagnik","family":"Bakshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2516-5146","authenticated-orcid":false,"given":"Supradip","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4204-7088","authenticated-orcid":false,"given":"Aritra","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5588-5526","authenticated-orcid":false,"given":"Raina","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9537-2346","authenticated-orcid":false,"given":"Shreyasi","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0345-1321","authenticated-orcid":false,"given":"Anwesha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6363-886X","authenticated-orcid":false,"given":"Upasana","family":"Baskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Provash Chandra","family":"Sadhukhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"issue":"10075","key":"10947_CR1","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease Lancet. 2017;389(10075):1238\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(16)32064-5.","journal-title":"Chronic Kidney Disease Lancet"},{"issue":"2","key":"10947_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.ki.5002017","volume":"71","author":"K Yamagata","year":"2007","unstructured":"Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population: A 10-year follow-up study. Kidney Int. 2007;71(2):159\u201366. https:\/\/doi.org\/10.1038\/sj.ki.5002017.","journal-title":"Kidney Int"},{"issue":"July","key":"10947_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20(July):473\u201385. https:\/\/doi.org\/10.1038\/s41581-024-00820-6.","journal-title":"Nat Rev Nephrol"},{"key":"10947_CR4","doi-asserted-by":"publisher","unstructured":"Timofte D, Dragos D, Balcangiu-Stroescu A-E, Tanasescu M-D, Balan D, Avino A, et al. Infection with hepatitis C virus in Hemodialysis patients: an overview of the diagnosis and prevention rules within a Hemodialysis center (Review). Exp Ther Med. 2020;109\u201316. https:\/\/doi.org\/10.3892\/etm.2020.8606.","DOI":"10.3892\/etm.2020.8606"},{"issue":"6","key":"10947_CR5","doi-asserted-by":"publisher","first-page":"644","DOI":"10.18502\/IJM.V12I6.5041","volume":"12","author":"A Madhavan","year":"2020","unstructured":"Madhavan A, Sachu A, Balakrishnan AK, Vasudevan A, Balakrishnan S, Vasudevapanicker J. Prevalence of hepatitis C among haemodialysis patients in a tertiary care hospital in South India. Iran J Microbiol. 2020;12(6):644. https:\/\/doi.org\/10.18502\/IJM.V12I6.5041.","journal-title":"Iran J Microbiol"},{"issue":"5","key":"10947_CR6","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ekir.2017.04.003","volume":"2","author":"SK Agarwal","year":"2017","unstructured":"Agarwal SK, Bagchi S, Yadav RK. Hemodialysis patients treated for hepatitis C using a Sofosbuvir-based regimen. Kidney Int Rep. 2017;2(5):831\u20135. https:\/\/doi.org\/10.1016\/j.ekir.2017.04.003.","journal-title":"Kidney Int Rep"},{"issue":"12","key":"10947_CR7","first-page":"1139","volume":"47","author":"SK Agarwal","year":"1999","unstructured":"Agarwal SK, Dash SC, Irshad M. Hepatitis C virus infection during haemodialysis in India. J Assoc Physicians India. 1999;47(12):1139\u201343.","journal-title":"J Assoc Physicians India"},{"issue":"MAR","key":"10947_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2018.00396","volume":"9","author":"G Shi","year":"2018","unstructured":"Shi G, Suzuki T. Molecular basis of encapsidation of hepatitis C virus genome. Front Microbiol. 2018;9(MAR):1\u20137. https:\/\/doi.org\/10.3389\/fmicb.2018.00396.","journal-title":"Front Microbiol"},{"key":"10947_CR9","unstructured":"World Health Organization. Global Hepatitis Report 2024."},{"key":"10947_CR10","unstructured":"Ministry of Health and Family Welfare G. National Action Plan Combating Viral Hepatitis in India. 2019;1\u201352."},{"key":"10947_CR11","doi-asserted-by":"publisher","unstructured":"Hedskog C, Parhy B, Chang S, Zeuzem S, Moreno C, Shafran SD, et al. Identification of 19 novel hepatitis C virus subtypes-further expanding HCV classification. Open Forum Infect Dis. 2019;6. https:\/\/doi.org\/10.1093\/ofid\/ofz076.","DOI":"10.1093\/ofid\/ofz076"},{"issue":"1","key":"10947_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mjafi.2018.08.001","volume":"75","author":"P Roy","year":"2019","unstructured":"Roy P, Patel A, Lole K, Gupta RM, Kumar A, Hazra S. Prevalence and genotyping pattern of hepatitis C virus among patients on maintenance Hemodialysis at five centers in Pune, India. Med J Armed Forces India. 2019;75(1):74\u201380.","journal-title":"Med J Armed Forces India"},{"key":"10947_CR13","doi-asserted-by":"publisher","unstructured":"Kalita D, Deka S, Chamuah K. Circulation of an atypical hepatitis C virus (HCV) strain at a dialysis unit in northeast India. Microbiologyopen. 2021;10(1):e1147. https:\/\/doi.org\/10.1002\/mbo3.1147","DOI":"10.1002\/mbo3.1147"},{"issue":"1","key":"10947_CR14","first-page":"1","volume":"1","author":"SRKD Venkatesh","year":"2018","unstructured":"Venkatesh SRKD. Diagnosis & management of viral hepatitis. Natl Heal Mission. 2018;1(1):1\u201380.","journal-title":"Natl Heal Mission"},{"key":"10947_CR15","unstructured":"Hepatitis C. Getting tested. Atlanta (GA): U.S. Department of Health and Human Services; https:\/\/www.cdc.gov\/hepatitis\/hcv\/pdfs\/hepcgettingtested.pdf"},{"issue":"5","key":"10947_CR16","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s12072-016-9717-6","volume":"10","author":"M Omata","year":"2016","unstructured":"Omata M, Kanda T, Wei L, Yu ML, Chuang WL, Ibrahim A, et al. APASL consensus statements and recommendation on treatment of hepatitis C. Hepatol Int. 2016;10(5):702\u201326.","journal-title":"Hepatol Int"},{"issue":"4","key":"10947_CR17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/jvh.12002","volume":"20","author":"R Firdaus","year":"2013","unstructured":"Firdaus R, Saha K, Sadhukhan PC. Rapid immunoassay alone is insufficient for the detection of hepatitis C virus infection among high-risk population. J Viral Hepat. 2013;20(4):290\u20133.","journal-title":"J Viral Hepat"},{"issue":"2","key":"10947_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4103\/0255-0857.129782","volume":"32","author":"K Saha","year":"2014","unstructured":"Saha K, Firdaus R, Biswas A, Mukherjee A, Sadhukhan PC. A novel nested reverse-transcriptase polymerase chain reaction method for rapid hepatitis C virus detection and genotyping. Indian J Med Microbiol. 2014;32(2):130\u20136.","journal-title":"Indian J Med Microbiol"},{"issue":"6","key":"10947_CR19","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/molbev\/msy096","volume":"35","author":"S Kumar","year":"2018","unstructured":"Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35(6):1547\u20139.","journal-title":"Mol Biol Evol"},{"key":"10947_CR20","first-page":"1330","volume":"16","author":"M Kimura","year":"1980","unstructured":"Kimura M. J Mol Evol \u00a9. 1980;16:1330.","journal-title":"J Mol Evol \u00a9"},{"issue":"4","key":"10947_CR21","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4):S117\u2013314.","journal-title":"Kidney Int"},{"issue":"3","key":"10947_CR22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/cld.1137","volume":"18","author":"A Anand","year":"2021","unstructured":"Anand A, Shalimar. Hepatitis C virus in India: challenges and successes. Clin Liver Dis (Hoboken). 2021;18(3):150\u20134. https:\/\/doi.org\/10.1002\/cld.1137.","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"6","key":"10947_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4254\/WJH.V6.I6.41","volume":"6","author":"YC Yu","year":"2014","unstructured":"Yu YC, Wang Y, He CL, Wang MR, Wang YM. Management of hepatitis C virus infection in Hemodialysis patients. World J Hepatol. 2014;6(6):419. https:\/\/doi.org\/10.4254\/WJH.V6.I6.41.","journal-title":"World J Hepatol"},{"key":"10947_CR24","doi-asserted-by":"publisher","unstructured":"Marcus EL, Tur-Kaspa R. Chronic hepatitis C virus infection in older adults. Clin Infect Dis. 2005;41(11):1606\u20131612. https:\/\/doi.org\/10.1086\/497597","DOI":"10.1086\/497597"},{"issue":"2","key":"10947_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cgh.2019.04.035","volume":"18","author":"S Seo","year":"2020","unstructured":"Seo S, Silverberg MJ, Hurley LB, et al. Prevalence of spontaneous clearance of hepatitis C virus infection doubled from 1998 to 2017. Clin Gastroenterol Hepatol. 2020;18(2):511\u20133. https:\/\/doi.org\/10.1016\/j.cgh.2019.04.035.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10947_CR26","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","volume":"73","author":"JM Pawlotsky","year":"2020","unstructured":"Pawlotsky JM, Negro F, Aghemo A, Berenguer M, Dalgard O, Dusheiko G, et al. EASL recommendations on treatment of hepatitis C: final update of the series\u2606. J Hepatol. 2020;73(5):1170\u2013218.","journal-title":"J Hepatol"},{"issue":"October","key":"10947_CR27","doi-asserted-by":"publisher","first-page":"105375","DOI":"10.1016\/j.meegid.2022.10537","volume":"105","author":"M Khedhiri","year":"2022","unstructured":"Khedhiri M, Ghedira K, Rajhi M, Hammemi W, Sadraoui A, Touzi H, et al. Overview of the epidemic history of hepatitis C uncommon subtypes 2i and 4d in Tunisia and in the world. Infect Genet Evol. 2022;105(October):105375. https:\/\/doi.org\/10.1016\/j.meegid.2022.10537.","journal-title":"Infect Genet Evol"},{"issue":"2","key":"10947_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S2468-1253(18)30382-0","volume":"4","author":"N Gupta","year":"2019","unstructured":"Gupta N, Mbituyumuremyi A, Kabahizi J, Ntaganda F, Muvunyi CM, Shumbusho F, et al. Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir\u2013sofosbuvir (SHARED): a single-arm trial. Lancet Gastroenterol Hepatol. 2019;4(2):119\u201326. https:\/\/doi.org\/10.1016\/S2468-1253(18)30382-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10947_CR29","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jhep.2019.09.021","volume":"71","author":"JM Pawlotsky","year":"2019","unstructured":"Pawlotsky JM. DAA failures in African patients with unusual HCV subtypes: hey! Didn\u2019t you know there was another world? J Hepatol. 2019;71(6):1070\u20132. https:\/\/doi.org\/10.1016\/j.jhep.2019.09.021.","journal-title":"J Hepatol"},{"key":"10947_CR30","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3389\/fmicb.2019.00814","volume":"10","author":"M Ye","year":"2019","unstructured":"Ye M, Chen X, Wang Y, Duo L, Zhang C, Zheng YT. Identification of a new HCV subtype 6xg among injection drug users in Kachin. Myanmar Front Microbiol. 2019;10:814. https:\/\/doi.org\/10.3389\/fmicb.2019.00814.","journal-title":"Myanmar Front Microbiol"},{"key":"10947_CR31","doi-asserted-by":"publisher","unstructured":"Vo-Quang, E., & Pawlotsky, J. M.'Unusual' HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment. Gut.2024; 73(9), 1570\u20131582. https:\/\/doi.org\/10.1136\/gutjnl-2024-332177","DOI":"10.1136\/gutjnl-2024-332177"},{"issue":"4","key":"10947_CR32","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1053\/jhep.2003.50157","volume":"37","author":"A Chowdhury","year":"2003","unstructured":"Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, Naik TN, Bhattacharya SK, Mazumder DN. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology. 2003;37(4):802\u20139. https:\/\/doi.org\/10.1053\/jhep.2003.50157.","journal-title":"Hepatology"},{"issue":"3","key":"10947_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/thalassrep13030016","volume":"13","author":"S Dutta","year":"2023","unstructured":"Dutta S, Biswas A, Bakshi S, Choudhury P, Das R, Nath S, et al. Molecular epidemiology of HCV infection among Multi-Transfused \u03b2-Thalassemia patients in Eastern India: A Six-Year observation. Thalass Rep. 2023;13(3):165\u201378.","journal-title":"Thalass Rep"},{"issue":"16","key":"10947_CR34","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/nejmoa1316366","volume":"370","author":"N Afdhal","year":"2014","unstructured":"Afdhal N, Reddy KR, Nelson DR, Lawitz E, Gordon SC, Schiff E, et al. Ledipasvir and Sofosbuvir for previously treated HCV genotype 1 infection. N Engl J Med. 2014;370(16):1483\u201393. https:\/\/doi.org\/10.1056\/nejmoa1316366.","journal-title":"N Engl J Med"},{"issue":"1","key":"10947_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jhep.2016.08.021","volume":"66","author":"S Pol","year":"2017","unstructured":"Pol S, Bourliere M, Lucier S, Hezode C, Dorival C, Larrey D, et al. Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients. J Hepatol. 2017;66(1):39\u201347. https:\/\/doi.org\/10.1016\/j.jhep.2016.08.021.","journal-title":"J Hepatol"},{"issue":"3","key":"10947_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.23750\/abm.v89i3.7718","volume":"89","author":"AL Zignego","year":"2018","unstructured":"Zignego AL, Monti M, Gragnani L. Sofosbuvir\/Velpatasvir for the treatment of hepatitis C virus infection. Acta Biomed. 2018;89(3):321\u201331. https:\/\/doi.org\/10.23750\/abm.v89i3.7718.","journal-title":"Acta Biomed"},{"key":"10947_CR37","doi-asserted-by":"crossref","unstructured":"Dietz J, Graf C, Berg CP, Port K, Deterding K, Buggisch P et al. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients. JHEP Rep. 2024;6(7).","DOI":"10.1016\/S0168-8278(23)00579-2"},{"issue":"12","key":"10947_CR38","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1111\/jvh.12989","volume":"25","author":"SG Lim","year":"2018","unstructured":"Lim SG, Phyo WW, Shah SR, Win KM, Hamid S, Piratvisuth T, et al. Findings from a large Asian chronic hepatitis C real-life study. J Viral Hepat. 2018;25(12):1533\u201342.","journal-title":"J Viral Hepat"},{"issue":"2","key":"10947_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S2468-1253(18)30343-1","volume":"4","author":"L Wei","year":"2019","unstructured":"Wei L, Lim SG, Xie Q, V\u0103n KN, Piratvisuth T, Huang Y, et al. Sofosbuvir\u2013velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial. Lancet Gastroenterol Hepatol. 2019;4(2):127\u201334.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10947_CR40","doi-asserted-by":"crossref","unstructured":"Vo-Quang E, Soulier A, Ndebi M, Rodriguez C, Chevaliez S, Leroy V et al. Virological characterization of treatment failures and retreatment outcomes in patients infected with unusual HCV genotype 1 subtypes. Vol. 78, Hepatology. 2023. 607\u2013620 p.","DOI":"10.1097\/HEP.0000000000000379"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10947-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10947-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10947-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T07:45:28Z","timestamp":1747381528000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10947-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10947"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10947-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Ethics Committee of the Indian Council of Medical Research-National Institute of Cholera and Enteric Diseases (ICMR-NICED; recently the name changed to ICMR-NIRBI), Kolkata (Approval number: A-1\/2016-IEC; date of approval: 03.10.2016). Informed consent was obtained from all subjects involved in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent from the participant"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"706"}}